MetaCap

Grace Therapeutics (GRCE) News

NASDAQ: GRCEHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.71-0.01 (-0.58%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

GRCE news summary

We found 4 recent headlines mentioning Grace Therapeutics (GRCE): 0 in the past week and 4 in the past 30 days, most often from Nasdaq, GlobeNewswire. For price context, GRCE is down 0.58% at $1.71. The most recent story, "Grace Therapeutics Q2 Loss Widens Without Prior-Year Warrant Gain; Advances GTx-104 Plans", was published by Nasdaq on Nov 13, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Grace Therapeutics headlines

Stocks mentioned alongside GRCE

Compare GRCE